Navigation Links
Alba Therapeutics Corporation and Shire plc Enter Into $325 Million ex-US, ex-Japan Licensing Agreement to Develop and Commercialize AT-1001
Date:12/14/2007

BALTIMORE, Dec. 14 /PRNewswire/ -- Alba Therapeutics Corporation announced today that it has entered into a strategic collaboration with Shire plc (LSE: SHP, Nasdaq: SHPGY, TSX: SHQ), to jointly develop AT-1001, Alba's lead inhibitor of barrier dysfunction in various gastrointestinal ("GI") disorders. Shire will receive rights to commercialize all forms of AT-1001 outside of the United States and Japan. Alba will retain all rights to commercialize AT-1001 in the United States and Japan.

Under the terms of the collaboration, Alba will receive an initial, non- refundable licensing payment of US$ 25 million. Joint development costs toward global approval of AT-1001 will be shared 50/50 after the completion of two Phase 2 studies for Celiac disease. Alba is eligible to receive over US$ 80 million if certain clinical, regulatory and launch milestones are met for certain GI indications. Additional milestone payments totaling over US$ 40 million per indication will also be payable to Alba if the Collaboration is expanded beyond GI indications. Alba is also eligible to receive up to US$ 220 million in sales-based milestones, as well as tiered royalties. Not including royalties and cost sharing, the deal is valued at over US$ 325 million if all milestones are achieved.

Dr. Blake M. Paterson, Alba's President & CEO said:

"We are pleased to enter into this partnership with Shire, which leverages the unique experience and expertise of both companies in developing therapies for GI disorders. The combination of Alba's barrier function technology and autoimmune development capabilities with Shire's proven track record in GI drug development and commercialization will greatly enhance our efforts to bring these novel therapies to patients."

Matthew Emmens, Shire's CEO said:

"Alba's products have the potential to be an excellent addition to our current gastrointestinal business. This technology should provide significant benefit to patients w
'/>"/>

SOURCE Alba Therapeutics Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
3. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
4. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
5. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
6. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
7. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
8. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
9. Amsterdam Molecular Therapeutics Reports Half Year Results 2007
10. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
11. Anesiva Grants Specific-Use License of Its Needle-Free Drug Delivery Technology to Particle Therapeutics for Diabetes Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... Contract Research Organization XenoTech, LLC , ... a new 41,500 ft2 facility. The planned move will ... 16825 W. 116th St. in Lenexa, KS. The new ... laboratory space, will remain in the Kansas City metro area, ... than twenty years ago. Remaining in the Kansas City ...
(Date:4/21/2015)... April 21, 2015 Merrimack Pharmaceuticals, Inc. (Nasdaq: ... multi-arm Phase 1 study of MM-141, a bispecific antibody ... an oral session by Dr. Mansoor Saleh , ... Annual Meeting in Philadelphia, PA. ... as a monotherapy and in combination with everolimus or ...
(Date:4/21/2015)... FOREST, Calif. , April 21, 2015 ... leading provider of advanced cryogenic logistics solutions ... including immunotherapies, stem cells, cell lines, clinical ... today announced that Dr. Mark W. ... at the 3rd Annual BioLogistics Summit in ...
(Date:4/21/2015)... CA (PRWEB) April 21, 2015 ... will sponsor and exhibit at the ACRP 2015 Global ... Lake City, Utah. The Association of Clinical Research Professionals ... clinical research conference solely focused on the conduct of ... training and development, and widely recognized industry certifications. , ...
Breaking Biology Technology:XenoTech Plans Expansion to New Global Headquarters after Impressive Revenue Growth in 2014 2XenoTech Plans Expansion to New Global Headquarters after Impressive Revenue Growth in 2014 3First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients 2First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients 3First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients 4First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients 5Cryoport to Present at the 3rd Annual BioLogistics Summit in San Francisco, CA 2Cryoport to Present at the 3rd Annual BioLogistics Summit in San Francisco, CA 3PRC Clinical Sponsors The ACRP 2015 Global Conference And Meets Biotech Companies in the Salt Lake City Area. 2
... Calif., July 28, 2011 Life Technologies Corporation (NASDAQ: ... ending June 30, 2011. Non-GAAP revenue for the second quarter ... $906 million reported for the second quarter of 2010. Excluding ... 3 percent compared to the same period prior year. ...
... July 27, 2011 SomaLogic, Inc. and ... that they have entered into an exclusive ... SOMAmers as critical and unique reagents in ... amplification and polymerase chain reaction (PCR) products. ...
... routinely discarded during the birth process, a newborn,s umbilical ... that can be collected and stored for future medical ... potential, published data shows that three out of four ... banking. In connection with Cord Blood Awareness ...
Cached Biology Technology:Life Technologies Announces Second Quarter 2011 Results 2Life Technologies Announces Second Quarter 2011 Results 3Life Technologies Announces Second Quarter 2011 Results 4Life Technologies Announces Second Quarter 2011 Results 5Life Technologies Announces Second Quarter 2011 Results 6Life Technologies Announces Second Quarter 2011 Results 7Life Technologies Announces Second Quarter 2011 Results 8Life Technologies Announces Second Quarter 2011 Results 9Life Technologies Announces Second Quarter 2011 Results 10Life Technologies Announces Second Quarter 2011 Results 11Life Technologies Announces Second Quarter 2011 Results 12Life Technologies Announces Second Quarter 2011 Results 13Life Technologies Announces Second Quarter 2011 Results 14Life Technologies Announces Second Quarter 2011 Results 15Life Technologies Announces Second Quarter 2011 Results 16Agreement Between SomaLogic and New England Biolabs Enables the Use of SOMAmer Technology for the Optimization of Multiple PCR Products 2Parent's Guide to Cord Blood Foundation Launches Nation's First Searchable Map of U.S. Sites for Donating Umbilical Cord Blood 2Parent's Guide to Cord Blood Foundation Launches Nation's First Searchable Map of U.S. Sites for Donating Umbilical Cord Blood 3
(Date:3/24/2015)... , March 24, 2015   NexID Biometrics ... critical security-authentication needs, today announced the beginning of shipments ... solution. The company, based in ... the three-day Connect:ID Expo, which began here today at ... said version 2.0 of its SDK boosts the accuracy ...
(Date:3/23/2015)... Conn. , Mar. 23, 2015 NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market, announces its ... new advertising campaign on CNBC television starting March 30 th ... will commence airing in New York ... Officer said: "We are excited about our new ad campaign ...
(Date:3/19/2015)... OXFORD, Conn. , March 19, 2015  NXT-ID, Inc. ... biometric authentication company focused on the growing mobile commerce market, ... featured in a news clip that aired this week on ... http://www.myfoxdc.com/ ) . In a segment "The Next ... smart wallet ,a new way to pay, and ,a really ...
Breaking Biology News(10 mins):NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 3NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3
... the National Science Foundation (NSF) totaling $3.4 million, the ... will add 300 teraflops to the TeraGrid,s total computational ... more than 200 million additional service units, or CPU ... to over 800 million and benefitting the organization,s entire ...
... with cooperation partners from the U.S., the researchers surrounding Prof. ... their discovery in a so-termed Rapid Communication in the prestigious ... Society (JACS). The journal,s independent reviewers evaluated the work ... Better than household antifreeze Temperatures of minus ...
... pollute our environment with a number of heavy metals ... alone, an estimated 70% of heavy metals in landfill ... bigger and cheaper every year, environmental costs continue to ... Aviv University solution applies a discovery in nano-technology, based ...
Cached Biology News:NICS to add more than 300 Teraflops to the NSF’s computing capacity 2Why fish don't freeze in the Arctic Ocean 2'Greening' your flat screen TV 2
... for ChIP assays. Efficient fixation of a ... crucial step for the Chromatin-immunoprecipitation (ChIP) technique. ... most important parameter. Two major problems concerning ... into account: first, an excess of crosslinking ...
... 300V (Cat. No. MP-300V) power supply is ... electrophoresis needs in a personal, single, easy ... power supply provides Constant Voltage or ... 4 pairs of terminator and the powerful ...
Rab GDP dissociation inhibitor beta...
... Drummond Scientific has a long and ... microinjection apparatus. Several years ago we ... displacement microdispenser was being modified to ... unit by redesigning the microdispenser to ...
Biology Products: